Literature DB >> 10828879

Extinction of rac1 and Cdc42Hs signalling defines a novel p53-dependent apoptotic pathway.

P Lassus1, P Roux, O Zugasti, A Philips, P Fort, U Hibner.   

Abstract

Apoptosis is a normal physiological process which eliminates cells that do not receive adequate extracellular signals. One of the pathways signalling apoptosis is controlled by the small GTPases of the Rho family, also involved in cell proliferation, differentiation and motility. Another major apoptosis signalling pathway involves the p53 tumour suppressor which is activated by a variety of stress and mediates growth arrest or apoptosis in normal cells. We show here that upon detachment from the extracellular matrix, fibroblasts undergo rapid apoptosis that can be rescued by constitutive activation of Rac1 and Cdc42Hs GTPases. Conversely, inhibition of Rac1 and Cdc42Hs efficiently triggers apoptosis in adherent cells. Interestingly, apoptosis is not observed in p53-/- cells either cultured in suspension or inhibited for Rac1 and Cdc42Hs activity. Moreover, Rac1 and Cdc42Hs extinction in normal cells activates endogenous p53. Using specific inhibitors of MAPK pathways, we demonstrate that, in our experimental system, p38 signals survival, while ERK activity is required for apoptosis. Our data constitute the first demonstration that Rac1 and Cdc42Hs control pathways that require simultaneous signalling through MAPK ERK and p53 to induce apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828879     DOI: 10.1038/sj.onc.1203553

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Suppression of extracellular signal-regulated kinase activity in herpes simplex virus 1-infected cells by the Us3 protein kinase.

Authors:  Uyanga Chuluunbaatar; Richard Roller; Ian Mohr
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells.

Authors:  Benjamin Chaigne-Delalande; Lynda Deuve; Edith Reuzeau; Caroline Basoni; David Lafarge; Christine Varon; Florence Tatin; Guerric Anies; Richard Garand; Ijsbrand Kramer; Elisabeth Génot
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.

Authors:  X Hu; Y Zhao; L Wei; B Zhu; D Song; J Wang; L Yu; J Wu
Journal:  Oncogene       Date:  2017-03-20       Impact factor: 9.867

4.  Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesis.

Authors:  Emily E Bosco; Wenjun Ni; Lei Wang; Fukun Guo; James F Johnson; Yi Zheng
Journal:  Blood       Date:  2010-02-23       Impact factor: 22.113

5.  Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt.

Authors:  O Zugasti; W Rul; P Roux; C Peyssonnaux; A Eychene; T F Franke; P Fort; U Hibner
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

Review 6.  Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.

Authors:  Diego de Sá Coutinho; Maria Talita Pacheco; Rudimar Luiz Frozza; Andressa Bernardi
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

7.  Mitochondrial genomic variation associated with higher mitochondrial copy number: the Cache County Study on Memory Health and Aging.

Authors:  Perry G Ridge; Taylor J Maxwell; Spencer J Foutz; Matthew H Bailey; Christopher D Corcoran; JoAnn T Tschanz; Maria C Norton; Ronald G Munger; Elizabeth O'Brien; Richard A Kerber; Richard M Cawthon; John S K Kauwe
Journal:  BMC Bioinformatics       Date:  2014-05-28       Impact factor: 3.169

Review 8.  The Role of Resveratrol in Cancer Therapy.

Authors:  Jeong-Hyeon Ko; Gautam Sethi; Jae-Young Um; Muthu K Shanmugam; Frank Arfuso; Alan Prem Kumar; Anupam Bishayee; Kwang Seok Ahn
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

9.  Phosphorylation of human TRM9L integrates multiple stress-signaling pathways for tumor growth suppression.

Authors:  Chen Gu; Jillian Ramos; Ulrike Begley; Peter C Dedon; Dragony Fu; Thomas J Begley
Journal:  Sci Adv       Date:  2018-07-11       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.